SAN JOSE, Calif., April 23, 2014 /PRNewswire/ -- Xilinx, Inc. (Nasdaq: XLNX) today announced fiscal 2014 sales of $2.38 billion, up 10% from the prior fiscal year. Fiscal 2014 net income increased 29% to $630 million, or $2.19 per diluted share, versus fiscal 2013 net income of $488 million or $1.79 per diluted share.

Logo - http://photos.prnewswire.com/prnh/20020822/XLNXLOGO

Fourth quarter fiscal 2014 sales were $618 million, up 5% sequentially and up 16% from the fourth quarter of the prior fiscal year. Fourth quarter fiscal 2014 net income was $156 million, or $0.53 per diluted share, including a $10 million loss, or $0.03 per diluted share, associated with the recent redemption of convertible notes.

Additional fourth quarter comparisons are represented in the charts below:


    GAAP Results

    (In millions, except EPS)

                                                                           Growth Rates

                                Q4             Q3              Q4

                              FY 2014        FY 2014        FY 2013         Q-T-Q       Y-T-Y
                              -------        -------        -------         -----       -----

     Net
     revenues                         $617.8         $586.8         $532.2           5%       16%

     Operating
     income                           $189.5         $202.7         $147.2          -7%       29%

     Net
     income                           $156.0         $175.9         $130.6         -11%       19%

     Diluted
     earnings
     per
     share                             $0.53          $0.61          $0.47         -13%       13%

"The tremendous success of our 28nm product portfolio has contributed to Xilinx PLD segment share gains for the third consecutive fiscal year," said Moshe Gavrielov, Xilinx President and Chief Executive Officer. "With March quarter sales exceeding $140 million, we have established an estimated 70% market segment share at 28nm for all of fiscal 2014, with leadership across all product families and broad adoption of our Vivado® Design Suite and UltraFast(TM) Design Methodology. Our proven formula for success is already bearing fruit at 20nm with the UltraScale(TM) family, which includes the PLD industry's only high-end product."



    Net Revenues by Geography:


                               Percentages                 Growth Rates

                                    Q4            Q3            Q4

                                 FY 2014       FY 2014       FY 2013       Q-T-Q     Y-T-Y
                                 -------       -------       -------       -----     -----

     North
     America                               27%         29%             31%       -2%        0%

     Asia
     Pacific                               43%         40%             34%       12%       48%

    Europe                                 21%         22%             26%        3%       -6%

    Japan                                   9%          9%              9%        2%       16%


    Net Revenues by End Market:


                                 Percentages           Growth Rates

                                      Q4         Q3         Q4

                                   FY 2014    FY 2014     FY 2013    Q-T-Q  Y-T-Y
                                   -------    -------     -------    -----  -----

    Communications & Data Center          49%      44%           44%    17%    30%

    Industrial, Aerospace &
     Defense                              34%      37%           37%    -3%     7%

    Broadcast, Consumer &
     Automotive                           15%      16%           17%    -4%     2%

    Other                                  2%       3%            2%   -23%     2%


    Net Revenues by Product:


                             Percentages                 Growth Rates

                                  Q4           Q3             Q4

                               FY 2014       FY 2014       FY 2013       Q-T-Q      Y-T-Y
                               -------       -------       -------       -----      -----

    New                                  42%         38%             27%        17%        85%

    Mainstream                           34%         33%             41%         8%        -5%

    Base                                 21%         26%             28%       -16%       -16%

    Support                               3%          3%              4%        10%         0%

Products are classified as follows:

New products: Kintex(TM) Ultrascale, Virtex®?7, Kinte?7, Artix(TM)-7, Zynq(TM)-7000, Virtex?6, Spartan(TM)?6 products
Mainstream products: Virtex?5, Spartan?3 and CoolRunner(TM)?II products
Base products: Virtex?4, Virtex?II, Virtex?E, Virtex, Spartan-II, Spartan, CoolRunner and XC9500 products
Support products: Configuration solutions, HardWire, Software & Support/Services


    Key Statistics:

    (Dollars in millions)


                                    Q4           Q3           Q4

                                 FY 2014      FY 2014      FY 2013
                                 -------      -------      -------


    Annual Return on Equity (%)*           22           20           17


    Operating Cash Flow                  $189         $216         $174


    Depreciation Expense                  $14          $14          $14


    Capital Expenditures                  $14          $11           $6


    Combined Inventory Days               115          114          110


    Revenue Turns (%)                      54           52           58



         *Return on equity calculation:
          Annualized net income/average
          stockholders' equity

Product and Financial Highlights - Fiscal 2014


    --  During fiscal year 2014, sales from Xilinx's 28nm product portfolio,
        which includes the 7 series FPGAs and the Zynq-7000 family, surpassed
        $380 million with material contributions from all product families. 28nm
        momentum has continued to grow, driven by a wide range of applications
        that includes next generation LTE wireless base stations, OTN,
        Datacenter, industrial networking, surveillance, electronic warfare and
        automotive driver assist.
    --  The Company continued to drive gross margin improvement, achieving a
        record 68.8% gross margin in fiscal year 2014, up from 66.0% in the
        prior fiscal year. This improvement reflects the Company's continued
        discipline and focus on driving gross margin expansion projects across
        our product portfolio.
    --  Xilinx generated over $800 million in operating cash flow in fiscal
        2014. Demonstrating a strong commitment to increase shareholder value,
        Xilinx paid its shareholders a record $267M in dividends and repurchased
        5.2 million shares for $242 million. Xilinx recently increased its
        quarterly dividend by $0.04 per share to $0.29 per share. Additionally,
        more favorable financial market conditions and a continued strong credit
        rating enabled Xilinx to issue $1 billion of senior notes, using the
        proceeds to redeem its 2007 convertible notes.
    --  Xilinx, in close partnership with TSMC, shipped the industry's first
        20nm device, Kintex Ultrascale, in November 2013 and we expect to ship
        the first Virtex Ultrascale devices during the June quarter.
    --  Xilinx announced the next generation Zynq UltraScale Multi-Processing
        SoC (MPSoC) Architecture targeted for 16nm.  The UltraScale MPSoC
        architecture extends Xilinx's ASIC-class UltraScale FPGA and 3D IC
        architectures to enable heterogeneous multi-processing SoCs with the
        right engines for the right tasks. Xilinx will be leveraging TSMC's
        FinFet + process, offering the highest performance FinFet transistors in
        the industry.

Business Outlook - June Quarter Fiscal 2015


    --  Sales are expected to be up 0% to 4% sequentially.
    --  Gross margin is expected to be approximately 68%.
    --  Operating expenses are expected to be approximately $220 million
        including $2.5 million of amortization of acquisition-related
        intangibles.
    --  Other income and expenses are expected to be a net expense of
        approximately $8 million.
    --  Fully diluted share count is expected to be approximately 286 million.
    --  June quarter tax rate is expected to be approximately 13% - 14%.

Conference Call

A conference call will be held today at 2:00 p.m. Pacific Time to discuss the March quarter financial results and management's outlook for the June quarter. The webcast and subsequent replay will be available in the investor relations section of the Company's web site at www.investor.xilinx.com. A telephonic replay of the call may be accessed later in the day by calling (855) 859-2056 and referencing confirmation code 8428806. The telephonic replay will be available for two weeks following the live call.

This release contains forward-looking statements and projections. Forward-looking statements and projections can often be identified by the use of forward-looking words such as "expect," "believe," "may," "will," "could," "anticipate," "estimate," "continue," "plan," "intend," "project" or other similar expressions. Statements that refer to or are based on projections, uncertain events or assumptions also identify forward-looking statements. Such forward looking statements include, but are not limited to, statements related to the semiconductor market, the growth and acceptance of our products, expected revenue growth, the demand and growth in the markets we serve, opportunity for expansion into new markets, and our expectations regarding our business outlook for the June quarter of fiscal 2015. Undue reliance should not be placed on such forward-looking statements and projections, which speak only as of the date they are made. We undertake no obligation to update such forward-looking statements. Actual events and results may differ materially from those in the forward-looking statements and are subject to risks and uncertainties including customer acceptance of our new products, current global economic conditions, the health of our customers and the end markets in which they participate, our ability to forecast end customer demand, a high dependence on turns business, more customer volume discounts than expected, greater product mix changes than anticipated, fluctuations in manufacturing yields, our ability to deliver product in a timely manner, our ability to successfully manage production at multiple foundries, variability in wafer pricing, costs and liabilities associated with current and future litigation, and other risk factors listed in our most recent Forms 10-Q and 10-K.

About Xilinx

Xilinx develops All Programmable technologies and devices, beyond hardware to software, digital to analog, and single to multiple die in 3D ICs. These industry leading devices are coupled with a next-generation design environment and IP to serve a broad range of customer needs, from programmable logic to programmable systems integration. For more information visit www.xilinx.com.

#1434F

Xilinx, the Xilinx logo, Artix, ISE, Kintex, Spartan, Virtex, Zynq, Vivado, and other designated brands included herein are trademarks of Xilinx in the United States and other countries. All other trademarks are the property of their respective owners.

XLNX-F

Investor Relations Contact:
Lori Owen
Xilinx, Inc.
(408) 879-6911
ir@xilinx.com

© Copyright 2014 Xilinx



    XILINX, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF INCOME

    (Unaudited)

    (In thousands, except per share amounts)

                                                    Three Months Ended                                  Twelve Months Ended
                                                    ------------------                                  -------------------

                                                March 29, 2014              December 28, 2013                               March 30, 2013          March 29, 2014            March 30, 2013
                                                --------------              -----------------                               --------------          --------------            --------------

    Net revenues                                                   $617,823                   $586,816                                     $532,168                $2,382,531                $2,168,652

    Cost of revenues                                                199,945                    180,792                                      180,589                   743,253                   737,206
                                                                    -------                    -------                                      -------                   -------                   -------

    Gross margin                                                    417,878                    406,024                                      351,579                 1,639,278                 1,431,446
                                                                    -------                    -------                                      -------                 ---------                 ---------

    Operating expenses:

    Research and development                                        127,812                    128,092                                      111,133                   492,447                   475,522

    Selling, general and
     administrative                                                  98,087                     91,794                                       90,732                   378,607                   365,684

    Amortization of acquisition-
     related intangibles                                              2,462                      2,589                                        2,487                     9,887                     9,508

    Litigation and contingencies                                          -                    (19,190)                                           -                     9,410                         -
                                                                        ---                    -------                                          ---                     -----                       ---

    Total operating expenses                                        228,361                    203,285                                      204,352                   890,351                   850,714
                                                                    -------                    -------                                      -------                   -------                   -------


    Operating income                                                189,517                    202,739                                      147,227                   748,927                   580,732

    Loss on extinguishment of
     convertible debentures                                           9,848                          -                                            -                     9,848                         -

    Interest and other expense,
     net                                                              3,819                      4,807                                        8,902                    29,553                    33,726
                                                                      -----                      -----                                        -----                    ------                    ------

    Income before income taxes                                      175,850                    197,932                                      138,325                   709,526                   547,006

    Provision for income taxes                                       19,823                     22,055                                        7,705                    79,138                    59,470
                                                                     ------                     ------                                        -----                    ------                    ------

    Net income                                                     $156,027                   $175,877                                     $130,620                  $630,388                  $487,536
                                                                   ========                   ========                                     ========                  ========                  ========

    Net income per common share:

    Basic                                                             $0.58                      $0.66                                        $0.50                     $2.37                     $1.86
                                                                      =====                      =====                                        =====                     =====                     =====

    Diluted                                                           $0.53                      $0.61                                        $0.47                     $2.19                     $1.79
                                                                      =====                      =====                                        =====                     =====                     =====

    Cash dividends per common
     share                                                            $0.25                      $0.25                                        $0.22                     $1.00                     $0.88
                                                                      =====                      =====                                        =====                     =====                     =====

    Shares used in per share calculations:

    Basic                                                           268,134                    267,780                                      263,035                   266,431                   261,652
                                                                    =======                    =======                                      =======                   =======                   =======

    Diluted                                                         294,536                    288,195                                      277,090                   287,396                   272,573
                                                                    =======                    =======                                      =======                   =======                   =======


    XILINX, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands)

                                                            March 29, 2014            March 30, 2013 *
                                                            --------------            ---------------

                                                             (unaudited)

    ASSETS

    Current assets:

    Cash, cash equivalents and
     short-term investments                                                $2,457,321                  $1,714,745

    Accounts receivable, net                                                  267,833                     229,175

    Inventories                                                               233,999                     201,250

    Deferred tax assets and other
     current assets                                                           107,994                     152,469

    Total current assets                                                    3,067,147                   2,297,639

    Net property, plant and
     equipment                                                                355,089                     365,687

    Long-term investments                                                   1,190,775                   1,651,033

    Other assets                                                              424,338                     415,092

    Total Assets                                                           $5,037,349                  $4,729,451
                                                                           ==========                  ==========



    LIABILITIES , TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY

    Current liabilities:

      Accounts payable and accrued
       liabilities                                                           $369,260                    $333,379

      Deferred income on shipments
       to distributors                                                         55,099                      53,358

      Deferred tax liabilities                                                      -                          51

      Current portion of long-term
       debt                                                                   565,001                           -

    Total current liabilities                                                 989,360                     386,788

    Long-term debt                                                            993,870                     922,666

    Deferred tax liabilities                                                  253,433                     415,442

    Other long-term liabilities                                                13,005                      41,259

    Temporary equity                                                           34,999                           -

    Stockholders' equity                                                    2,752,682                   2,963,296

    Total Liabilities, Temporary
     Equity and Stockholders'
     Equity                                                                $5,037,349                  $4,729,451
                                                                           ==========                  ==========



    * Derived from audited financial statements



    XILINX, INC.

    SUPPLEMENTAL FINANCIAL INFORMATION

    (Unaudited)

    (In thousands)

                                              Three Months Ended                                Twelve Months Ended
                                              ------------------                                -------------------

                                          March 29, 2014              December 28, 2013                             March 30, 2013         March 29, 2014         March 30, 2013
                                          --------------              -----------------                             --------------         --------------         --------------

    SELECTED CASH FLOW INFORMATION:

    Depreciation                                              $13,860                   $13,595                                    $13,893                $55,464                $56,327

    Amortization                                                4,980                     5,058                                      4,355                 19,808                 17,233

    Stock-based compensation                                   25,961                    24,339                                     21,246                 94,314                 77,862

    Net cash provided by
     operating activities                                     189,375                   216,390                                    173,653                804,917                656,537

    Purchases of property,
     plant and equipment                                       14,148                    10,975                                      6,212                 44,865                 30,265

    Payment of dividends to
     stockholders                                              67,042                    67,096                                     57,822                267,343                230,469

    Repurchases of common stock                                73,955                    97,140                                          -                241,076                197,689

    Proceeds from issuance of
     common stock to employees
     and excess tax benefit                                   111,301                    12,729                                     59,671                268,912                117,872


    STOCK-BASED COMPENSATION INCLUDED IN:

    Cost of revenues                                           $1,974                    $1,966                                     $1,638                 $7,602                 $6,356

    Research and development                                   12,723                    11,912                                     10,256                 46,197                 37,937

    Selling, general and
     administrative                                            11,264                    10,461                                      9,352                 40,515                 33,569

SOURCE Xilinx, Inc.